Vascular Medicine

Jody A. Charnow

February 25, 2022

Frailty may be useful for informing clinical decision-making regarding choice of vascular access.

Brandon May

February 24, 2021

Rivaroxaban plus aspirin regimen for chronic atherosclerotic vascular disease may not require adjustment based on BMI or weight.

Next post in Cardiovascular Disease (CVD)

Guideline-Directed Pharmacotherapies for HFrEF and Survival Outcomes in Patients With Comorbid Low BP and Renal Dysfunction